Executive Summary

This report traces the historical trajectory of Vitamin D, from the ancient recognition of rickets to contemporary research on its multifaceted physiological roles and ongoing public health debates. It highlights key scientific breakthroughs, public health interventions, and the evolving understanding of this essential nutrient, now recognized as a prohormone.

1. Introduction: The Ancient Shadow of Rickets

1.1 Early Descriptions and Recognition of Skeletal Deformities

Rickets and osteomalacia, characterized by a failure of normal mineralization of bone and epiphyseal cartilage, are among the earliest diseases to be described. Rickets specifically impacts growing infants and children, affecting both bone and epiphyseal cartilage, leading to skeletal deformity.¹

Ancient observations of skeletal deformities date back as early as 300 B.C., with Lu-pu-wei’s descriptions of crooked legs and hunchback, though these references were ambiguous and could be associated with other disorders. More specific clinical observations emerged from Chinese physicians in the seventh and eighth centuries A.D., who noted symptoms such as enlarged head, body wasting, pigeon breast, and delayed walking. By the tenth century, Chien-i, often referred to as the “Father of Chinese pediatrics,” documented numerous cases of rickets.¹ In the second century A.D., Soranus of Ephesus mentioned characteristic deformities of the legs and spine in young children and notably remarked on the higher frequency of these conditions in urban Rome compared to Greece. Slightly later, Galen’s work also included descriptions of skeletal deformities in infants and young children, particularly knock-knee, bow leg, and funnel-shaped or pigeon breast chests.¹

The definitive recognition of rickets as a distinct disease entity came in the mid-17th century. Daniel Whistler provided a clear scientific description in the Netherlands in 1645, detailing a condition where the skeleton was poorly mineralized and deformed. This was followed by Francis Glisson’s seminal work, “De Rachitide,” first published in Latin in 1650 and later translated into English in 1671. Glisson’s book provided the first documented records, featuring lithographs of children exhibiting the characteristic bowing of the legs and other skeletal deformities that are hallmarks of vitamin D deficiency.¹ The progression of clinical recognition, from vague ancient accounts to specific diagnostic features documented by Whistler and Glisson, illustrates how medical observation and documentation become refined over centuries, laying the foundational understanding for subsequent investigations into the disease’s causes.

1.2 The “English Disease” and the Impact of Industrialization

Rickets was a widespread condition in the Roman Empire and remained common well into the 20th century.⁵ The 18th and 19th centuries witnessed a significant surge in rickets cases, particularly in the burgeoning industrialized cities of northern Europe.³ The prevalence was so high that literary figures like Charles Dickens depicted characters such as Tiny Tim in “A Christmas Carol,” whose deformed skeleton clearly represented a common sight in the dark, polluted cities of late 19th-century England.³

In London, during the peak of the Industrial Revolution, the combination of persistent thick fog and heavy industrial smog severely blocked sunlight, leading to an alarming incidence where up to 80 percent of children exhibited varying degrees of rickets. This widespread affliction earned it the moniker “the English Disease” in several foreign languages, including German, Dutch, Hungarian, and Swedish.⁵ Similarly, in the United States, as cities like Boston and New York experienced rapid growth in the late 1800s, rickets cases surged, with reports indicating that over 80 percent of children in Boston suffered from the condition by 1900.⁴

A pivotal, though initially unheeded, observation was made by Polish physician Jedrzej Sniadecki in 1840. He documented a stark differential incidence of rickets between city-dwellers and rural-dwellers in Warsaw, speculating that a lack of sunlight or fresh air was involved in the disease’s etiology. His views, however, were poorly received at the time, as the notion that sunlight could have a beneficial effect on the skeleton seemed inconceivable.³ This early hypothesis, despite its initial dismissal, foreshadowed the later discovery of vitamin D’s synthesis in the skin via ultraviolet (UV) light, demonstrating the importance of diverse lines of inquiry in scientific breakthroughs. The dramatic increase in rickets during the Industrial Revolution, particularly in dense urban centers, and its designation as “the English Disease,” clearly illustrates a strong environmental cause-and-effect. Industrialization led to crowded, polluted cities with significantly reduced sunlight exposure. This, combined with existing physiological factors like darker skin pigmentation (which has more melanin and thus a lower ability to produce vitamin D from sunlight), and cultural practices that limit sun exposure (such as wearing long garments, even in sun-rich regions like the Middle East), created a perfect storm for widespread vitamin D deficiency.⁵ This highlights how profound societal and environmental changes can impact public health, even for conditions with a seemingly simple nutritional basis.

Table 1: Key Milestones in Vitamin D Discovery (Chronological)

Date	Event	Key Individuals/Institutions	Significance
300 B.C.	Early descriptions of crooked legs/hunchback (ambiguous rickets)	Lu-pu-wei	Earliest known, though non-specific, observations of skeletal deformities.
2nd Century A.D.	Descriptions of skeletal deformities, urban prevalence	Soranus of Ephesus, Galen	More specific clinical observations, first noted urban-rural disparity.
1645	First clear scientific description of rickets	Daniel Whistler	Established rickets as a distinct disease entity.
1650	First documented records of rickets (“De Rachitide”)	Francis Glisson	Provided detailed clinical descriptions and illustrations, solidifying recognition.
1840	Hypothesis linking rickets to lack of sunlight (urban vs. rural)	Jedrzej Sniadecki	Early, though initially unheeded, insight into environmental factors.
1918-1919	Cod liver oil identified as anti-rachitic factor	Sir Edward Mellanby	Demonstrated a dietary component crucial for rickets prevention.
1919	UV light demonstrated to cure rickets	Kurt Huldschinsky	Provided experimental evidence for sunlight’s curative effect.
1922	Isolation and naming of “Vitamin D”	Elmer McCollum, Marguerite Davis	Identified a distinct fat-soluble vitamin (fourth discovered) essential for bone health.
1924-1925	Irradiation of food/animals produces Vitamin D	Harry Steenbock, Alfred Hess	Demonstrated that an inactive lipid could be converted to the anti-rachitic factor by UV light, paving the way for fortification.
1931	Chemical characterization of Vitamin D2 (Ergocalciferol)	Adolf Windaus and colleagues, Askew et al.	First elucidation of a vitamin D chemical structure.
1935-1936	Chemical characterization of Vitamin D3 (Cholecalciferol)	Adolf Windaus and colleagues	Identified the natural form synthesized in skin.
1930s	Widespread food fortification with Vitamin D (e.g., milk in US)	US Government, public health initiatives	Major public health intervention leading to near eradication of rickets.
1967-1971	Discovery of Vitamin D metabolism and active form (1,25-(OH)2D)	Hector DeLuca, Michael Holick, Tony Norman	Transformed understanding of vitamin D from a simple vitamin to a prohormone with hormonal activity.
1969-1973	Discovery of the Vitamin D Receptor (VDR)	Various researchers	Provided the molecular basis for vitamin D’s actions, indicating its role as a steroid-like hormone.
1987	Cloning and sequencing of the VDR	Various researchers	Confirmed vitamin D as part of a true steroid-like hormone system.
21st Century	Accumulation of evidence for extra-skeletal effects	Numerous researchers globally	Expanded understanding of vitamin D’s roles in immunity, cardiovascular health, cancer, etc.

2. The Quest for the Anti-Rachitic Factor: Early 20th Century Discoveries

2.1 Initial Observations: Sunlight, Cod Liver Oil, and Rickets

By the late 1700s, some medical practitioners, including Percival in the UK, began advocating the use of cod liver oil for the treatment of rickets, suggesting a nutritional component to the disease.³ This practice gained traction, and cod liver oil became an early, albeit empirically used, treatment. The 19th century saw rickets affecting over 90% of children in urban, polluted environments in Europe, underscoring the urgency of finding effective interventions.⁴

In the early 20th century, pioneering studies began to rigorously demonstrate the curative properties of both cod liver oil and sunlight. Kurt Huldschinsky in Austria, in 1919, made a significant discovery: exposing rachitic children to summer sunlight or artificial ultraviolet (UV) light could cure the disease. This finding was further supported by Harriette Chick and her colleagues in 1923, who conducted similar experiments.³ The simultaneous observation that both a dietary factor (cod liver oil) and an environmental factor (sunlight/UV light) could cure rickets was a critical turning point. This was not a contradiction but a strong indication that they might be related through a common underlying mechanism or a single “anti-rachitic” substance. This convergence of seemingly disparate observations set the stage for the scientific community to search for this unifying factor.

2.2 Pioneering Research: Mellanby, McCollum, Steenbock, and the Naming of Vitamin D

The search for the anti-rachitic factor intensified in the early 20th century. In 1918-1919, Sir Edward Mellanby conducted conclusive experiments using dogs, demonstrating that a component in cod liver oil was crucial for preventing rickets. Although he did not identify the exact substance, he correctly concluded that the anti-rachitic action of certain fats was due to a fat-soluble vitamin or “accessory food factor”.⁴

Following Mellanby’s work, in 1922, American scientists Elmer McCollum and Marguerite Davis made a groundbreaking discovery while conducting experiments on rats. They successfully isolated the “antirachitic factor” and, recognizing it as distinct from vitamin A, named it “vitamin D,” as it was the fourth vitamin to be identified.² McCollum’s research established vitamin D as an essential substance for preventing rickets, leading to the widespread medical use of cod-liver oil.²

Concurrently, Harry Steenbock, between 1924 and 1925, made another pivotal discovery: ultraviolet irradiation of food and animals could produce vitamin D. He correctly concluded that an inactive lipid present in both diet and skin could be converted into an active anti-rachitic substance by UV light.⁹ Steenbock’s work was particularly impactful because he developed a method for fortifying milk with vitamin D and, crucially, patented the process. This strategic decision to patent the discovery attracted industry investment, enabling the widespread application of this method and playing a significant role in the eventual elimination of rickets as a major public health problem.¹³ Alfred Hess independently made similar discoveries around the same time.¹⁰ The interconnectedness of dietary and environmental factors became clear through these discoveries. Mellanby’s work established the dietary link, while Huldschinsky’s confirmed the sunlight link. Steenbock’s breakthrough provided the crucial connection: UV light could create the anti-rachitic factor. This revealed that vitamin D was unique among vitamins in that it was not solely dependent on dietary intake but could be synthesized endogenously. This understanding was pivotal, moving beyond simple nutritional deficiency to recognizing a complex interplay with environmental factors.

2.3 Elucidating the Chemical Structures: Vitamin D2 and D3

The common term “vitamin D” actually refers to two major forms: vitamin D2, known as ergocalciferol, and vitamin D3, known as cholecalciferol.¹⁵ The precise chemical structures of these forms were elucidated primarily by Adolf Windaus and his colleagues in Germany during the 1920s and 1930s.⁴ Windaus’s groundbreaking research into the constitution of sterols and their connection with vitamins earned him the Nobel Prize in Chemistry in 1928.⁴

Vitamin D2 was chemically characterized in 1931, having been isolated from irradiated ergosterol, a mycosterol found in fungi.¹⁰ Subsequently, vitamin D3 was chemically characterized in 1935-1936. It was shown to result from the ultraviolet irradiation of 7-dehydrocholesterol, a precursor compound found naturally in the skin.⁴ Windaus’s team established its structure by meticulously investigating the photochemical reactions involved in its formation.²¹ Chemically, both vitamin D2 and D3 are classified as secosteroids, meaning that one of the bonds in their steroid rings is broken. Their structural difference lies in their side chains.¹⁹ The elucidation of these precise chemical structures was a monumental achievement, transforming the understanding of vitamin D from a mysterious “factor” to a defined molecule. This knowledge was essential for its synthesis, standardization, and a deeper understanding of how UV light transforms precursors into active forms, marking a significant transition from observational biology to molecular chemistry in the field.

The evolutionary history of vitamin D is remarkably deep, predating complex life forms. The presence of ergosterol (provitamin D2) in ancient phytoplankton, existing over 750 million years ago, and its conversion to previtamin D2 upon sunlight exposure, suggests that vitamin D or its precursors are likely among the oldest hormones, dating back over 1.5 billion years.⁶ It has been speculated that the UV absorption properties of provitamin D2 and previtamin D2 initially served as a protective mechanism for early photosynthetic eukaryotes, shielding their DNA, RNA, and proteins from damaging solar ultraviolet radiation. Furthermore, the thermal isomerization of previtamin D2 into a non-planar vitamin D2 structure could have caused a structural change in the plasma membrane, potentially opening a tiny pore that permitted the entrance of calcium and other cations into the cell.⁶ This ancient association between sunlight, vitamin D, and calcium may explain their intimate relationship in vertebrates. When vertebrate life forms transitioned from calcium-rich oceans to calcium-poor land environments, the ability to produce vitamin D3 in the skin during sun exposure, thereby increasing the efficiency of calcium absorption, became critically advantageous for maintaining a healthy skeleton.⁶ This broader evolutionary perspective elevates vitamin D beyond a simple nutrient to a fundamental biological regulator with deep roots in the history of life.

3. Unraveling the Mechanism: Metabolism and Receptors

3.1 Discovery of Active Metabolites: 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D

Vitamin D, whether derived from food sources or synthesized in the skin through sunlight exposure, is initially an inactive form.¹¹ For it to exert its numerous biological effects, it must undergo a process of activation involving two sequential hydroxylation reactions within the body.¹¹ The intricate metabolism of vitamin D was first described in 1967, marking a significant advancement in understanding its physiological role.³

Upon ingestion or synthesis, vitamin D (D2 or D3) is absorbed into the lymph via chylomicrons and transported to the liver.¹¹ In the liver, it undergoes its first hydroxylation, catalyzed primarily by the enzyme CYP2R1, to form 25-hydroxyvitamin D (25(OH)D), also known as calcifediol. This compound is the main circulating metabolite of vitamin D and serves as the primary indicator of an individual’s vitamin D status.¹⁶

Subsequently, 25(OH)D is transported to the kidneys, where it undergoes a second hydroxylation. This crucial step is catalyzed by the enzyme CYP27B1, also known as 1α-hydroxylase, resulting in the formation of 1,25-dihydroxyvitamin D (1,25-(OH)2D), or calcitriol. Calcitriol is the biologically active, hormonal form of vitamin D, responsible for most of its physiological actions.³ The identification of calcitriol as the active form was a landmark achievement in 1971, attributed to Michael F. Holick, working in the laboratory of Hector DeLuca, and also to Tony Norman and their colleagues.¹⁰ Following its discovery, calcitriol was approved for medical use in the United States in 1978.²⁵ The production of 1,25(OH)2D in the kidney is tightly regulated, stimulated by parathyroid hormone (PTH) and inhibited by calcium, phosphate, and fibroblast growth factor 23 (FGF23).¹⁶ This discovery of sequential hydroxylation steps and the identification of 1,25-(OH)2D as the biologically active form fundamentally shifted the understanding of vitamin D. It revealed that vitamin D is not merely a dietary vitamin but a prohormone, requiring metabolic activation, much like steroid hormones. This reclassification reflects a deeper understanding of its complex regulatory role in the body, moving beyond simple nutrient deficiency to recognizing a sophisticated endocrine system.

3.2 Identification and Significance of the Vitamin D Receptor (VDR)

The understanding of vitamin D’s mechanism of action was further revolutionized by the discovery and characterization of a specific receptor molecule, later termed the Vitamin D Receptor (VDR).²⁴ Serum 1,25(OH)2D, the active form, binds with this nuclear VDR, which functions as a transcription factor, to induce the expression of various vitamin D target genes.¹⁰ The VDR was initially discovered in 1969, though at that time it was recognized only as a binding protein for an as-yet-unknown vitamin D metabolite. Its full characterization, including cloning and sequencing, was achieved in 1987.¹⁶

The cloning of the VDR provided definitive molecular evidence, confirming that the vitamin D hormone system operates akin to a true steroid-like hormone system. Its physiological functions are mediated through receptor-dependent activities that are mechanistically similar to those of other steroid endocrine systems.²⁴ The critical role of the VDR is underscored by the fact that inactivating mutations in this receptor lead to hereditary vitamin D resistant rickets (HVDRR), a severe bone disorder. Furthermore, animal models in which the VDR has been genetically “knocked out” exhibit the full phenotype of severe vitamin D deficiency, unequivocally demonstrating that the VDR is the major mediator of vitamin D action in the body.¹⁶

Perhaps one of the most significant aspects of the VDR’s discovery was its widespread distribution. While initially found in classic target tissues involved in calcium and phosphate homeostasis, such as the intestine, bone, kidney, and parathyroid glands, it became clear that the VDR is widely distributed throughout many different body tissues.¹⁰ This broad expression hinted at a much larger spectrum of biological functions for vitamin D beyond its classical role in mineral regulation, laying the groundwork for extensive research into its extra-skeletal roles in immunity, cancer, and other systems. The identification and cloning of the VDR provided the molecular mechanism by which vitamin D exerts its effects. Crucially, the discovery of VDRs in a wide array of tissues beyond those directly involved in calcium homeostasis implied that vitamin D’s influence was far more extensive than previously understood. This demonstrated that a single hormone could have diverse effects by interacting with specific receptors in different cell types, providing the molecular basis for its pleiotropic actions.

3.3 The Intricate Pathway of Vitamin D Synthesis and Activation

The synthesis and activation of vitamin D involve a sophisticated multi-step pathway. Vitamin D3 is naturally produced in the skin upon exposure to ultraviolet (UV) irradiation. This process begins when UV light breaks a bond in the B ring of 7-dehydrocholesterol, a precursor molecule found in the skin, to form pre-vitamin D3. Pre-vitamin D3 then undergoes a rapid thermal isomerization to become vitamin D3.¹⁰

Once formed, vitamin D3 is preferentially removed from the skin and enters the bloodstream, where it is bound to vitamin D binding protein (DBP). DBP serves as a transport protein for vitamin D and its metabolites throughout the circulation, and it also plays an immunomodulatory role.¹⁰ The liver and other tissues then metabolize this circulating vitamin D, whether from skin synthesis or oral ingestion, into 25-hydroxyvitamin D (25(OH)D), the principal circulating form.¹⁶

The final activation step occurs primarily in the kidneys, where 25(OH)D is further metabolized to 1,25-dihydroxyvitamin D (1,25(OH)2D) by the enzyme CYP27B1 (1α-hydroxylase). While the kidney is the main site for this conversion, other tissues, including various epithelial cells, cells of the immune system, and the parathyroid gland, also possess this enzyme and can produce 1,25(OH)2D for local, paracrine/autocrine functions.¹⁶ The production of 1,25(OH)2D in the kidney is tightly controlled, stimulated by parathyroid hormone (PTH) and inhibited by calcium, phosphate, and FGF23, ensuring precise regulation of mineral homeostasis.¹⁶

To maintain balance, the body also has mechanisms for catabolizing vitamin D metabolites. The major enzyme responsible for the breakdown of both 25(OH)D and 1,25(OH)2D is 24-hydroxylase (CYP24A1). This enzyme initiates the catabolic pathway that ultimately leads to the formation of calcitroic acid, which is then excreted.¹⁶ Furthermore, research has uncovered alternative pathways of vitamin D activation, initiated by the enzyme P450scc (CYP11A1). These pathways produce novel metabolites, such as 20-hydroxyvitamin D3, which are found in tissues like the placenta, adrenal glands, and epidermal keratinocytes, and also exhibit biological activity as hormones.²⁰ The detailed understanding of vitamin D synthesis and activation, involving multiple organs (skin, liver, kidney) and specific enzymes, reveals a highly sophisticated endocrine system. The tight control of 1,25(OH)2D production by PTH, calcium, and phosphate demonstrates a finely tuned feedback loop essential for mineral homeostasis. The discovery of alternative metabolic pathways further emphasizes the complexity and adaptability of this system, suggesting redundancy and specialized functions in different tissues.

4. A Public Health Triumph: Fortification and Rickets Eradication

4.1 The Genesis of Food Fortification Programs

Following the groundbreaking discoveries of vitamin D and the understanding that UV irradiation could effectively produce it, the stage was set for large-scale public health interventions.² Before the widespread availability of synthetic vitamin D, various methods were employed to combat rickets, including the use of irradiated milk, cod liver oil, and even milk from yeast-fed cattle.²⁶ Elmer McCollum’s pioneering work in 1922, which clearly demonstrated the efficacy of cod-liver oil in preventing rickets, led to its widespread adoption in medical practice.²

The concept of fortifying staple foods with essential micronutrients gained momentum in the early 20th century. Switzerland led the way in 1923 by fortifying salt with iodine to combat goiter, a public health issue at the time, followed by the United States in 1924.²⁶ This established a crucial precedent for widespread micronutrient fortification programs. Building on this success and the scientific breakthroughs in vitamin D, the US government took decisive action, imposing food fortification with vitamin D, initially in common staples like bread and milk.¹² The 1930s specifically marked the widespread introduction of vitamin D fortification in milk across the U.S..²⁶ The industrial-scale synthesis of various vitamin and mineral compounds in the 1930s and 1940s made widespread food fortification technically and economically feasible, allowing for significant public health impact.²⁷ The journey from Mellanby’s observation of an anti-rachitic factor to the widespread fortification of milk represents a monumental public health achievement. This was not a spontaneous event but a deliberate policy decision, facilitated by scientific breakthroughs (such as Steenbock’s irradiation patent and Windaus’s structural elucidation allowing synthesis) and a recognized public health crisis (widespread rickets). This illustrates the critical role of collaboration between scientists, public health officials, and industry in translating knowledge into effective, population-level interventions.

4.2 Global Impact and Success Stories in Combating Deficiency

The introduction of vitamin D supplements and, more significantly, the widespread fortification of foods, particularly milk, dramatically reduced the incidence of rickets cases in developed countries, virtually eliminating the disease as a major public health concern.² This population-level intervention proved highly effective.

Studies have consistently shown that fortifying dairy products, cereals, fats, oils, and other food items effectively increased serum 25-hydroxyvitamin D levels across populations.²⁸ While various fortification methods were employed, research indicated that vitamin D3 demonstrated superior efficacy over vitamin D2 in raising serum 25-OH D levels.²⁸ Furthermore, advancements in food science, such as encapsulation techniques, improved the stability and bioavailability of vitamin D in fortified products.²⁸ Fortifying staple foods like milk and eggs proved to be a highly cost-effective public health strategy when compared with pharmaceutical interventions. For instance, fortification efforts were shown to increase vitamin D intake nearly five-fold cost-effectively versus relying on prescription drugs.²⁹ The near eradication of rickets in developed nations through food fortification is a compelling demonstration of the impact of population-level public health interventions. Unlike individual prescriptions, fortification reaches a broad segment of the population, including vulnerable groups, in a cost-effective manner. The superior efficacy of D3 over D2 and the development of encapsulation techniques show the continuous refinement of these interventions for maximum impact.

Despite these significant successes, nutritional rickets continues to affect a substantial number of infants and children worldwide, particularly in countries in Asia, the Middle East, and some parts of Africa. This persistence is often attributed to inadequate implementation of supplementation policies or co-existing calcium deficiency, highlighting that even effective interventions require consistent global implementation and addressing underlying socioeconomic factors.³⁰

5. Beyond Bone Health: Expanding Physiological Horizons

5.1 Classical Role in Calcium and Phosphate Homeostasis

The initial and classical understanding of vitamin D’s physiological function centered on its critical role in maintaining calcium and phosphate concentrations within their normal physiological ranges. This function is absolutely essential for the proper mineralization of bone and the development of a healthy skeleton.³

Vitamin D achieves this by promoting the absorption of both calcium and phosphate in the small intestine. It also plays a role in mobilizing calcium from bone when systemic levels are low and enhances the renal reabsorption of calcium, thereby preventing its excessive loss in urine.³ A discovery in 1952 revealed that vitamin D can also cause the mobilization of calcium from bone into the circulation, a process that might appear counterproductive for bone strength. However, this action is a crucial part of its complex regulatory role to maintain systemic calcium levels, ensuring that vital physiological processes dependent on calcium can continue even when dietary intake is insufficient.¹⁰ Without adequate vitamin D or calcium, the parathyroid glands compensate by producing excessive amounts of parathyroid hormone (PTH), a condition known as hyperparathyroidism. This can lead to bone weakening, increasing the risk of conditions like osteoporosis and fractures.³¹ This foundational role in mineral metabolism underscores vitamin D’s function as a key regulator and highlights its hormonal control over mineral balance, reinforcing the shift in its classification from a simple vitamin to a prohormone.

5.2 Emerging Understanding of Immune System Modulation

The identification of vitamin D receptors (VDRs) in numerous body tissues, notably including various immune cells, signaled that vitamin D’s functions extended far beyond its established role in calcium and phosphate homeostasis.¹⁰ Evidence of these extra-skeletal effects, particularly on innate and acquired immunity, began to accumulate significantly in the 21st century.¹⁰

Early observations, predating the discovery of vitamin D itself, hinted at this connection. In 1903, Nils Finsen was awarded the Nobel Prize for demonstrating that concentrated light irradiation could cure epidermal tuberculosis (lupus vulgaris), foreshadowing the link between light, vitamin D, and immune function. Later, oral vitamin D supplementation was successfully used to treat lupus vulgaris and other mycobacterial infections like leprosy.³² While these were early clinical observations, the molecular understanding emerged much later. In 2006, genome-wide analyses revealed the pathogen-induction of an intracrine vitamin D system in monocytes and elucidated a mechanism for vitamin D’s anti-mycobacterial actions.³² This is a classic example of scientific knowledge being rediscovered and then elucidated at a deeper, mechanistic level.

Mechanistically, vitamin D enhances the innate immune response by inducing the production of antimicrobial proteins, such as cathelicidin and β-defensin 2. These proteins form a crucial first line of defense against invading pathogens and may contribute to preventing upper respiratory tract infections.¹⁰ Furthermore, vitamin D modulates the adaptive immune system, influencing processes like antigen presentation, T-cell proliferation, and overall T-cell phenotype, generally contributing to the suppression of excessive inflammation.³² This sophisticated immunomodulatory role, far beyond its initial perception as a bone vitamin, highlights the complex interplay between vitamin D and the immune system.

5.3 Investigations into Cardiovascular Health, Cancer, and Autoimmune Diseases

Beyond its classical role in bone health and its emerging role in immunity, vitamin D has been the subject of extensive research into its potential influence on a wide array of other chronic diseases.

Cardiovascular Health: Vitamin D plays a role in cardiovascular health by acting on endothelial and smooth muscle tissues to regulate blood pressure.¹⁸ Epidemiological studies have suggested an inverse association between circulating 25-hydroxyvitamin D levels and cardiovascular disease events, with higher cardiovascular disease mortality observed during winter months and in regions with less solar UV-B exposure.³⁴ However, randomized controlled trials (RCTs) investigating vitamin D’s direct impact on cardiovascular outcomes have yielded mixed or null results, indicating that more rigorous and targeted research is needed to establish definitive causal links.³³

Cancer: Early ecological studies provided indirect evidence linking sun exposure (and thus vitamin D production) to lower rates of internal cancers. For instance, Peller’s work in 1936 and 1937, and Apperly’s in 1941, noted an inverse correlation between solar radiation and total cancer mortality.³⁶ In 1974, Cedric and Frank Garland hypothesized that vitamin D could reduce the risk of colorectal cancer, observing lower rates in sunny southwest U.S. states compared to higher rates in the northeast. They later found support for this hypothesis with dietary vitamin D and calcium intake, and prediagnostic serum 25(OH)D concentrations.³⁶ Mechanistically, vitamin D has been shown to inhibit cancer cell growth by inducing apoptosis (programmed cell death), decreasing metastatic spread, arresting cells at specific phases of the cell cycle, and downregulating proliferation signals.¹⁰ While meta-analyses of randomized trials suggest a lower death rate from cancer in those assigned to vitamin D, particularly for advanced cancers, some studies evaluating its impact on cancer incidence and overall death have yielded less conclusive results, underscoring the need for further research.³³

Autoimmune Diseases: Vitamin D deficiency is frequently observed in individuals with autoimmune diseases and has been linked to more severe disease progression and worse outcomes.⁴⁰ Research suggests a crucial role for vitamin D in regulating the immune system, particularly during childhood. A study from McGill University found that vitamin D deficiency early in life can accelerate the aging of the thymus, an organ responsible for training immune cells to distinguish the body’s own tissues from harmful invaders. This premature aging makes the thymus less effective at filtering out immune cells that could mistakenly attack healthy tissues, thereby increasing the risk of autoimmune diseases like Type 1 diabetes.⁴¹ Furthermore, one study demonstrated that long-term daily supplementation with 2,000 IU of vitamin D reduced the incidence of autoimmune diseases by 22% over five years.⁴⁰

For cardiovascular disease and cancer, there is a recurring pattern: strong associations observed in epidemiological and ecological studies, but often inconclusive or null results in randomized controlled trials. This discrepancy is a major theme in contemporary vitamin D research. It suggests that observational correlations might be due to confounding factors (e.g., healthier individuals spending more time outdoors), or that trial designs (such as dose, duration, or baseline vitamin D status of participants) are often inadequate for a nutrient with pleiotropic, long-term effects. This highlights the inherent challenges in designing definitive trials for nutrients compared to pharmaceuticals, where a clear dose-response and specific mechanism can be more easily isolated.

5.4 Recent Insights into Aging and Neurodegenerative Conditions

The scope of vitamin D research continues to expand, with recent insights pointing to its potential roles in biological aging and neurodegenerative conditions. Vitamin D deficiency has been linked to a loss of brain plasticity and has been identified as a risk factor for young-onset dementia.³³ Through the presence of vitamin D receptors (VDRs) in the brain, vitamin D may protect neurons, improve cognitive capacity, and potentially reduce the incidence of neurodegenerative diseases.¹⁸

Perhaps one of the most intriguing recent findings comes from randomized controlled trials suggesting that vitamin D supplementation may slow biological aging. These studies indicate that vitamin D helps maintain telomeres, the protective caps at the ends of chromosomes that naturally shorten with age and are associated with an increased risk of age-related diseases. One trial observed that vitamin D3 supplementation significantly reduced telomere shortening over four years, preventing the equivalent of nearly three years of biological aging.³⁸ The emerging research linking vitamin D to aging, telomere length, and neurodegenerative diseases signifies a new frontier in vitamin D research. These are complex, multifactorial conditions, and finding a role for vitamin D suggests its influence extends to fundamental cellular processes beyond its classical roles. The telomere finding, in particular, points to a potential mechanism for slowing biological aging, which has profound implications for long-term health and disease prevention. This illustrates the dynamic and ever-expanding nature of scientific inquiry into this “sunshine vitamin.”

Table 2: Evolution of Vitamin D’s Physiological Roles

Time Period/Phase	Primary Focus	Key Discoveries/Understanding	Examples of Effects
Ancient Times – Early 20th Century	Rickets and Osteomalacia (Skeletal Deformities)	Clinical recognition of bone deformities, link to urban living, initial observations of cod liver oil and sunlight as treatments.	Softening and weakening of bones, delayed growth, skeletal deformities (bow legs, knock-knees, pigeon breast).
Mid-20th Century (Post-Discovery)	Calcium and Phosphate Homeostasis	Elucidation of metabolic activation (25(OH)D, 1,25(OH)2D), identification of VDR, understanding its role in intestinal absorption, bone mobilization, and renal reabsorption of minerals.	Essential for bone mineralization, prevention of osteoporosis, regulation of serum calcium and phosphate levels.
Late 20th Century – Present	Extra-Skeletal Functions (Immune, Cardiovascular, Cancer, Autoimmune, Neurodegenerative)	Widespread VDR distribution in diverse tissues, epidemiological associations, mechanistic insights into cell differentiation, proliferation, apoptosis, and immune modulation.	Enhancing innate immunity, modulating adaptive immunity, potential roles in reducing cancer risk/mortality, influencing cardiovascular function (BP regulation), protecting neurons, slowing biological aging (telomere length).

6. Contemporary Debates and Future Directions in Vitamin D Research

6.1 Controversies Surrounding Optimal Levels and Supplementation Guidelines

Despite the widespread recognition of vitamin D’s importance, there remains significant uncertainty and ongoing controversy regarding the precise daily doses needed to maintain optimal levels in the general population, as well as specific recommendations for supplementation.³⁰ Different prominent organizations propose varying thresholds for defining vitamin D status and recommended intakes, reflecting the complexity and evolving nature of the scientific understanding.

The Institute of Medicine (IOM), now part of the National Academies of Sciences, Engineering, and Medicine (NASEM), defines vitamin D status categories based on serum 25(OH)D concentrations: deficient at less than 12 ng/mL (30 nmol/L), insufficient between 12 and 20 ng/mL (30-50 nmol/L), and sufficient at or above 20 ng/mL (50 nmol/L). They also note potential adverse effects linked to levels greater than 50 ng/mL (125 nmol/L), particularly above 60 ng/mL (150 nmol/L).⁴³ Their Recommended Dietary Allowances (RDAs) or Adequate Intakes (AIs) generally range from 400 IU (10 mcg) for infants to 800 IU (20 mcg) for adults over 70 years, with 600 IU (15 mcg) for most individuals aged 1-70 years, including pregnant and lactating women.³³

In contrast, GrassrootsHealth, a public health organization, advocates for a higher consensus recommended range for general health, proposing 40-60 ng/mL (100-150 nmol/L) based on evidence linking these levels to a reduced risk of various diseases. They suggest that levels above 60 ng/mL may offer additional benefits for conditions like breast cancer prevention, psoriasis, asthma, rheumatoid arthritis, and tuberculosis. Levels between 60 and 100 ng/mL are considered the high end of a normal range, with concerns for toxicity typically arising above 150 ng/mL, and most frequently diagnosed when levels exceed 200 ng/mL.⁴⁶

The Endocrine Society defines vitamin D deficiency as serum 25(OH)D levels below 30 ng/mL (75 nmol/L).⁴³ While they do not identify a single threshold for sufficiency in healthy individuals, they recommend routine vitamin D supplementation for specific vulnerable groups, including children and teens aged 1 to 18 years, pregnant women, pre-diabetic patients, and adults aged 75 years and older, but not for healthy adults aged 19-74. They generally advise adherence to the established RDAs but do not recommend routine testing of 25(OH)D concentrations in healthy individuals.⁴⁴

Vitamin D toxicity is a rare occurrence, typically requiring extremely high doses, such as 50,000 IU or more daily for prolonged periods, or blood levels exceeding 200 ng/mL, which can lead to hypercalcemia (high blood calcium).⁴³ It is impossible to overdose on vitamin D from sun exposure alone.⁴³ The existence of widely differing guidelines for optimal vitamin D levels and supplementation is a significant and ongoing area of discussion. This indicates that despite decades of research, there is not a definitive scientific consensus on what constitutes “optimal” vitamin D status for all health outcomes beyond preventing overt deficiency diseases like rickets. This complexity arises from varying study designs, populations, outcome measures, and the challenge of establishing causality for a nutrient with broad physiological effects. It underscores the need for continued research and harmonization of guidelines to provide clearer public health recommendations.

6.2 Challenges in Clinical Trial Design and Interpretation

A persistent challenge in vitamin D research, particularly concerning its extra-skeletal benefits, lies in the design and interpretation of randomized controlled trials (RCTs). Results from many recent RCTs have been inconclusive due to questionable study designs, inappropriate treatment regimens, or the baseline vitamin D status of the participants.³⁰ Common methodological flaws include enrolling participants who are already vitamin D sufficient, using doses of vitamin D that may be too low to elicit a significant effect, and conducting studies over durations that are too short to observe long-term outcomes for chronic diseases.⁴⁷

A recurring pattern observed is the discrepancy between strong associations found in observational studies and the often null or mixed results from RCTs. For example, observational studies frequently show strong links between higher vitamin D levels and lower rates of certain diseases like cancer and cardiovascular disease, but RCTs often fail to replicate these benefits.³⁴ This divergence may be attributed to reverse causation, where healthier individuals who are more active and spend more time outdoors naturally have superior vitamin D status, rather than vitamin D directly causing improved health outcomes.¹⁰ This highlights the inherent difficulties in establishing causality for a nutrient that is endogenously produced and has broad, subtle effects over a lifetime. Furthermore, assay methodologies for measuring 25(OH)D concentration, the primary indicator of vitamin D status, remain a critical and controversial issue, contributing to variability in defining vitamin D status across studies.³⁰ The repeated observation that well-designed observational studies show strong associations, while many RCTs yield inconclusive results for vitamin D’s extra-skeletal benefits, points to fundamental methodological challenges in nutrient research. Unlike pharmaceuticals, nutrients have complex baseline statuses, endogenous production, and long-term, subtle effects. Trials often fail to account for these nuances, using insufficient doses, short durations, or enrolling participants who are already replete. This highlights the need for innovative trial designs that consider the unique physiological context of nutrients and acknowledge the limitations of applying drug trial paradigms directly to nutritional interventions.

6.3 The Path Forward: Unanswered Questions and Research Frontiers

Despite the significant historical progress in understanding vitamin D, the field remains highly dynamic, with numerous unanswered questions and active research frontiers.¹¹ Ongoing research endeavors aim to clarify the exact beneficial effects of vitamin D, particularly for the prevention and treatment of various health conditions, and to determine the appropriate dosages required to achieve these effects.¹¹

New areas of investigation are exploring the intricate relationship between vitamin D and the gut microbiome, as well as its influence on antitumor immunity.³³ Research also continues into vitamin D’s potential impact on biological aging, including its effects on telomere length, and its role in neurodegenerative diseases such as young-onset dementia.³³ The critical importance of vitamin D in early life for immune system development and its lasting effects on immune function and susceptibility to infections, particularly in children, remains a key area of focus.⁴⁰

Looking ahead, future research will likely emphasize personalized medicine approaches. These will consider individual genetic factors, such as VDR polymorphisms, along with lifestyle, environmental exposures, and baseline vitamin D status, to tailor recommendations for optimal health.³⁷ The enduring complexity and promise of vitamin D research are evident in these ongoing efforts. Despite significant historical progress, the field remains highly dynamic, with numerous unanswered questions and active research frontiers. The shift towards understanding its role in complex, multifactorial conditions like cancer, autoimmune diseases, and neurodegeneration, and even biological aging, demonstrates that vitamin D is far more than just a bone nutrient. The ongoing discussions, particularly around optimal levels and trial design, indicate a maturing scientific discipline grappling with the nuances of a pleiotropic hormone. This suggests that future research will likely focus on personalized approaches, genetic predispositions, and long-term, real-world outcomes to fully unlock the potential of this vital compound.

Table 3: Comparative Guidelines for Vitamin D Status and Intake

Organization	Vitamin D Status Categories (25(OH)D levels)	Recommended Daily Intake (RDA/AI)
Institute of Medicine (IOM)/NASEM	– Deficient: <12 ng/mL (30 nmol/L)- Insufficient: 12 to <20 ng/mL (30 to <50 nmol/L)- Sufficient: ≥20 ng/mL (≥50 nmol/L)- Potential Adverse Effects: >50 ng/mL (>125 nmol/L), particularly >60 ng/mL (>150 nmol/L)	– 0-12 months: 400 IU (10 mcg)- 1-70 years: 600 IU (15 mcg)- >70 years: 800 IU (20 mcg)- Pregnancy/Lactation: 600 IU (15 mcg)
GrassrootsHealth	– Recommended Range (General Health): 40-60 ng/mL (100-150 nmol/L)- Potential Additional Benefit (e.g., breast cancer): >60 ng/mL- High End of Normal: 60-100 ng/mL- Concern for Toxicity: >150 ng/mL (often diagnosed >200 ng/mL)	Not specified as a universal RDA, but emphasizes achieving target blood levels.
Endocrine Society	– Deficiency: <30 ng/mL (75 nmol/L)- Sufficiency: Not specifically identified as a single threshold for healthy individuals, but recommends supplementation for specific vulnerable groups.	Adherence to RDA (e.g., 400 IU for infants, 600 IU for older children, 400-600 IU for pregnant women, 400-800 IU for older adults). Routine supplementation for children and teens (1-18 years), pregnant women, pre-diabetic patients, and adults ≥75 years.

7. Conclusion: A Dynamic History, A Vital Future

The history of vitamin D is a compelling testament to the iterative and evolving nature of scientific discovery. It began with the ancient recognition of a crippling bone disease, rickets, and progressed through centuries of observation, culminating in the molecular elucidation of a complex pleiotropic prohormone. The journey from Sir Edward Mellanby’s identification of an anti-rachitic factor in cod liver oil to Harry Steenbock’s groundbreaking work on UV irradiation and Adolf Windaus’s precise structural determinations laid the essential scientific foundation. This knowledge was then successfully translated into a monumental public health triumph: the near eradication of rickets in many developed nations through widespread food fortification.

The discovery of the vitamin D receptor and the subsequent understanding of its extensive distribution across various body tissues ushered in a new era of research. This period revealed vitamin D’s vital roles extending far beyond bone health, encompassing critical functions in immune modulation, cardiovascular health, cancer prevention and survival, autoimmune disease management, and even influencing biological aging and neurodegenerative conditions.

Despite these profound advancements, contemporary debates persist, particularly regarding the optimal circulating levels of vitamin D and the most effective guidelines for supplementation across diverse populations. The challenges inherent in designing and interpreting clinical trials for a nutrient with such broad physiological effects underscore the need for continued, rigorous, and innovative research. Future investigations will likely focus on personalized approaches, integrating genetic predispositions, lifestyle factors, and individual baseline vitamin D status to unlock the full potential of this vital compound. The “sunshine vitamin” thus remains a dynamic and fascinating area of research, continually revealing new insights into human health and disease.

Works cited

1. Rickets and Osteomalacia (VIII.118) – The Cambridge World History of Human Disease, accessed June 25, 2025, https://www.cambridge.org/core/books/cambridge-world-history-of-human-disease/rickets-and-osteomalacia/C99DA38CF6C5436DCF3BCBD9073D8B13
2. McCollum Names Vitamin D and Pioneers Its Use Against Rickets – EBSCO, accessed June 25, 2025, https://www.ebsco.com/research-starters/history/mccollum-names-vitamin-d-and-pioneers-its-use-against-rickets
3. 100 YEARS OF VITAMIN D: Historical aspects of vitamin D – PMC, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9066576/
4. A Short Circular History of Vitamin D from its Discovery to its Effects, accessed June 25, 2025, https://journals.ed.ac.uk/resmedica/article/download/1031/1525/0
5. Rickets – Wikipedia, accessed June 25, 2025, https://en.wikipedia.org/wiki/Rickets
6. The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D3: Historical, Personal Experience and Evidence-Based Perspectives – MDPI, accessed June 25, 2025, https://www.mdpi.com/2072-6643/15/3/593
7. Rickets – Symptoms & causes – Mayo Clinic, accessed June 25, 2025, https://www.mayoclinic.org/diseases-conditions/rickets/symptoms-causes/syc-20351943
8. Rickets | Better Health Channel, accessed June 25, 2025, https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/rickets
9. Vitamin D discovery | EBSCO Research Starters, accessed June 25, 2025, https://www.ebsco.com/research-starters/nutrition-and-dietetics/vitamin-d-discovery
10. Vitamin D – The Physiological Society, accessed June 25, 2025, https://www.physoc.org/magazine-articles/vitamin-d/
11. The Power of Vitamin D: Is the Future in Precision Nutrition through Personalized Supplementation Plans? – MDPI, accessed June 25, 2025, https://www.mdpi.com/2072-6643/16/8/1176
12. The story of a vitamin for bone health that upgraded to hormone for systemic good health – Mattioli 1885 Journals, accessed June 25, 2025, https://mattioli1885journals.com/index.php/MedHistor/article/download/7766/7724/31641
13. History of the discovery of vitamin D and its active metabolites – PMC, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3899558/
14. The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D3: Historical, Personal Experience and Evidence-Based Perspectives, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9919777/
15. en.wikipedia.org, accessed June 25, 2025, https://en.wikipedia.org/wiki/Vitamin_D#:~:text=The%20common%2Duse%20term%20%22vitamin,ultraviolet%20irradiation%20of%207%2Ddehydrocholesterol.
16. Vitamin D: Production, Metabolism, and Mechanism of Action – Endotext – NCBI Bookshelf, accessed June 25, 2025, https://www.ncbi.nlm.nih.gov/books/NBK278935/
17. The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D3: Historical, Personal Experience and Evidence-Based Perspectives – PubMed, accessed June 25, 2025, https://pubmed.ncbi.nlm.nih.gov/36771300/
18. Vitamin D: Beyond Traditional Roles—Insights into Its Biochemical Pathways and Physiological Impacts – MDPI, accessed June 25, 2025, https://www.mdpi.com/2072-6643/17/5/803
19. Vitamin D – Wikipedia, accessed June 25, 2025, https://en.wikipedia.org/wiki/Vitamin_D
20. An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases, accessed June 25, 2025, https://www.mdpi.com/1422-0067/23/17/9784
21. Adolf Windaus – Wikipedia, accessed June 25, 2025, https://en.wikipedia.org/wiki/Adolf_Windaus
22. The Discovery of Vitamin D: The Contribution of Adolf Windaus – ResearchGate, accessed June 25, 2025, https://www.researchgate.net/publication/8534173_The_Discovery_of_Vitamin_D_The_Contribution_of_Adolf_Windaus
23. Vitamin D: calcium and bone homeostasis during evolution – PMC, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3899559/
24. The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights – JCI, accessed June 25, 2025, https://www.jci.org/articles/view/88887
25. Calcitriol – Wikipedia, accessed June 25, 2025, https://en.wikipedia.org/wiki/Calcitriol
26. A Brief History of Food Fortification in the U.S., accessed June 25, 2025, https://foodinsight.org/is-food-fortification-necessary-a-historical-perspective/
27. FOOD FORTIFICATION – Global Agribusiness – International Finance Corporation, accessed June 25, 2025, https://www.ifc.org/content/dam/ifc/doc/2023/foodfortificationleafletscombined-ifc-2023.pdf
28. (PDF) The Impact and Efficacy of Vitamin D Fortification – ResearchGate, accessed June 25, 2025, https://www.researchgate.net/publication/387096048_The_Impact_and_Efficacy_of_Vitamin_D_Fortification
29. The Impact and Efficacy of Vitamin D Fortification – PMC – PubMed Central, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11677708/
30. Controversies in Vitamin D: A Statement From the Third International Conference – PMC, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7745884/
31. Vitamin D and Calcium | Johns Hopkins Medicine, accessed June 25, 2025, https://www.hopkinsmedicine.org/health/wellness-and-prevention/vitamin-d-and-calcium
32. Impact of vitamin D on immune function: lessons learned from genome-wide analysis, accessed June 25, 2025, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2014.00151/full
33. Vitamin D – What’s the Latest Research? | Technology Networks, accessed June 25, 2025, https://www.technologynetworks.com/applied-sciences/articles/vitamin-d-whats-the-latest-research-383192
34. Vitamin D and Cardiovascular Disease – PMC, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3449318/
35. Vitamin D and cardiovascular health – PMC – PubMed Central, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7770490/
36. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms – PMC, accessed June 25, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9003337/
37. Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies – MDPI, accessed June 25, 2025, https://www.mdpi.com/2072-6694/16/18/3211
38. Vitamin D supplements may slow biological aging – Harvard Gazette, accessed June 25, 2025, https://news.harvard.edu/gazette/story/2025/05/vitamin-d-supplements-may-slow-biological-aging/
39. Vitamin D – The Nutrition Source, accessed June 25, 2025, https://nutritionsource.hsph.harvard.edu/vitamin-d/
40. New Research on Vitamin D and T-Cells: How It Can Improve Patient Care in Autoimmune Diseases – AiArthritis, accessed June 25, 2025, https://www.aiarthritis.org/vitamind-acr24
41. How vitamin D deficiency can lead to autoimmune diseases | Newsroom – McGill University, accessed June 25, 2025, https://www.mcgill.ca/newsroom/channels/news/how-vitamin-d-deficiency-can-lead-autoimmune-diseases-360580
42. academic.oup.com, accessed June 25, 2025, https://academic.oup.com/jcem/article/104/2/234/5148139#:~:text=Other%20controversial%20topics%20included%20the,actions%20of%20vitamin%20D%2C%20and
43. What Vitamin D Dosage Is Best? – Healthline, accessed June 25, 2025, https://www.healthline.com/nutrition/vitamin-d-dosage
44. Vitamin D – Health Professional Fact Sheet – NIH Office of Dietary Supplements, accessed June 25, 2025, https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
45. Normal vitamin D levels by age, sources, and toxicity – Medical News Today, accessed June 25, 2025, https://www.medicalnewstoday.com/articles/normal-vitamin-d-levels
46. Is Your Vitamin D Level Too High? – GrassrootsHealth, accessed June 25, 2025, https://www.grassrootshealth.net/blog/vitamin-d-level-high/
47. Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines – MDPI, accessed June 25, 2025, https://www.mdpi.com/2072-6643/17/2/277